08:00 – 08:15 AM EST – Opening ceremony (15 min)

08:15 – 09:45 AM EST –  Session 1: What I always wanted to know from other specialists? (90 min)

1. Surgeon’s perspective (7 min)

Vincent Fang (China)

2. Radiologist’s perspective (7 min)

Jeanne Ackman (USA)

3. Pathologist’s perspective (7 min)

Anja Roden (USA)

4. Neurologist’s perspective (7 min)

Mohammad Ashraghi (UK)

5. Radiation oncologist’s perspective (7 min)

Charles Simone (USA)

6. Medical oncologist’s perspective (7 min)

Chul Kim (USA)

7. Case presentation – Consequences of the lack of communication (10 min)

…

Q&A (30 min), moderators: Andreas Rimner (USA), Edith Marom (Israel)

09:45 – 10:00 AM EST – BREAK

10:00 – 11:15 AM EST – Session 2:  Lymph node involvement in thymic epithelial tumors (1 hr 15 min)

1. Imaging of mediastinal lymph nodes (CT, MRI, PET/CT) (10 min)

Chad Strange (USA)

2. Nodal dissection in TETs – how much is enough? (10 min)

Wing Kea Hui (Belgium)

3. pN factor in pathological report (10 min)

Malgorzata Szolkowska (Poland)

4. Radiation oncology treatment fields: nodal coverage and target volume delineation (10 min)

Florit Marcuse (Netherlands)

5. Survival in relation to nodal involvement in TET (10 min)

Chuong Hoang (USA)

Q&A (25 min), moderators: Paul Van Schil (Belgium), Andrea Bezjak (USA)

11:15 – 11:30 AM EST – BREAK

11:30 – 12:30 AM EST – POSTER SESSSION

08:00 – 09:30 AM EST – Session 3: Lung carcinomas vs. thymic carcinomas (90 min)

1. The role of minimally invasive surgery in lung carcinomas and in thymic carcinomas (15 min)

Joshua Sonett (USA)

2. Biomarkers for targeted therapies in lung carcinomas and in thymic carcinomas – state-of-the-art and future perspectives (15 min)

Jan von der Thüsen (Netherlands)

3. Radiation therapy for lung carcinomas and for thymic carcinomas (15 min)

Conrad Falkson (Canada)

4. Molecular targeted therapies and immunotherapy in lung carcinomas and in thymic carcinomas (15 min)

Sukhmani Padda (USA)

Q&A (30 min), moderators: Nicolas Girard (France), Dariusz Kowalski (Poland)

09:30 – 09:45 EST – BREAK

09:45 – 10:55 AM EST – Session 4: Complications and side effects of the treatment in TETs  (1 hr 10 min)

1. The most important complications of surgical treatment of TETs (10 min)

Dirk Van Raemdonck (Belgium)

2. Side effects of radiotherapy for TETs (10 min)

Annemarie Shepherd (USA)

3. Cardiotoxicity and other longterm toxicities of chemotherapy for TETs (10 min)

Sebastian Szmit (Poland)

4. Autoimmune side effects of immunotherapy for TETs (10 min)

Arun Rajan (USA)

Q&A (30 min), moderators: Stephanie Peeters (Netherlands), James Huang (USA)

10:55 – 11:10 AM EST – BREAK

11:10 -12:30 AM EST – ORAL ABSTRACT SESSION

Moderators: Tibor Krajc (Austria), Andrea Arrossi (USA)

08:00 – 09:10 AM EST – Session 5: Multi-system syndromes associated with thymic malignancies (70 min)

1. Multisystem disease features associated with thymic malignancies – setting the clinical scenario and its relevance (10 min)

Maria Isabel Leite (UK)

2. Heart involvement in thymic malignancies (10 min)

Efstratios Koutroumpakis (USA)

3. CNS autoimmunity associated with thymic malignancies – spectrum of clinical and laboratory features and management approach (10 min)

Daniele Velardo (Italy)

4. Patients with myasthenia gravis and dilemmas: to use or not neuromuscular blocker; postoperative care for ward or ICU? (10 min)

Zerrin Sungur (Turkey)

Q&A (30 min), moderators: Anna Kostera-Pruszczyk (Poland), Alexander Marx (Germany)

09:10 – 09:25 AM EST – BREAK

09:25 – 10:35 AM EST  – Session 6: GREAT DEBATE: Adjuvant treatment in TETs (70 min)

1. Postoperative radiation therapy (PORT) in TNM stage II and stage III TETs  – YES! (10 min)

Maggie Harris (UK)

2. Postoperative radiation therapy (PORT) in TNM stage II and stage III TETs  – NO! (10 min)

Mitsugu Omasa (Japan)

Q&A (15 min), moderator: Stephen Chun (USA)

3. Adjuvant chemotherapy – YES! (10 min)

Julian Molina, USA

4. Adjuvant chemotherapy – NO! (10 min)

Heather Wakelee (USA)

Q&A (15 min), moderator: Frank Detterbeck (USA)

10:35 – 10:50 AM EST – BREAK

10:50 – 12:10 AM EST – Tumor Board (80 min)

Presenter: Andrew Brownlee (USA)

Expert panel: Andre Moreira (USA) – pathologist, Katarzyna Blasinska (Poland) – diagnostic radiologist, Giuseppe Cardillo (Italy) – surgeon, Ritsuko Komaki (USA) – radiation oncologist, Nicolas Girard (France) – medical oncologist

Moderator: Alper Toker (USA)

12:10 – 12:15 AM EST – BREAK

12:15 – 12:30 AM EST – Closing ceremony (15 min)